Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis
Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis
Not yet recruiting · NCT06609343 · Registry updated 2026-08-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis | Chronic Disease, Disease Attributes, Fatigue, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-08-11 | NCT06609343 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The University of Texas Health Science Center at San Antonio | 127 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University Hospital Dialysis Medical Center (DMC) | San Antonio | United States | 1 |